Digal, Metchelyn C.
HRN: 27-11-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2025
MUPIROCIN 2%, 15G (TUBE)
07/02/2025
07/09/2025
TOPICAL
15g
BID
S/P Flat Inset And Nasal Dorsal Reconstruction
Waiting Final Action
Indication: Prophylaxis Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes